PSC
AMPH icon

Piper Sandler & Co’s Amphastar Pharmaceuticals AMPH Stock Holding History

Piper Sandler & Co’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-8,428
Closed -$98K – 132
2014
Q3 		$98K Buy
+8,428
New +$87.8K 0.05% 103

Other funds holding AMPH

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
FCE
Fiera Capital (Europe) Grand Cayman, Cayman Islands $213M AUM 42.35% 1-Year Est. Return

Piper Sandler & Co's AMPH Position: Q4 2014 in Review

Piper Sandler & Co sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2014, closing a stake of 8,428 shares — an estimated $98K sold.

Piper Sandler & Co first reported a position in AMPH in Q3 2014 and held it in 1 quarter. The position peaked at $98K in Q3 2014. 55 funds tracked by Wall St. Rank hold AMPH as of Q4 2014.

  • Piper Sandler & Co reported no remaining Amphastar Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Piper Sandler & Co sold 8,428 Amphastar Pharmaceuticals shares in Q4 2014, an estimated $98K.
  • Piper Sandler & Co first reported a position in Amphastar Pharmaceuticals in Q3 2014 and held it in 1 quarter.
  • Piper Sandler & Co's Amphastar Pharmaceuticals position peaked at $98K in Q3 2014.
  • 55 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2014.

Based on Piper Sandler & Co's 13F filing for Q4 2014, filed 17 Feb 2015.